Daewoong¡¯s Phase 3 trial of Covid-19 cure for severely ill patients cleared in Korea
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
The company said on Monday that the Ministry of Food and Drug Safety approved the trial of the investigational oral protease inhibitor in combination with remdesivir, the current standard antiviral to combat Covid-19, at the end of last year.
Foistar, which has been used to treat chronic pancreatitis, is being repurposed to treat coronavirus patients by the pharmaceutical company.
The Phase 3 trial will involve 1,072 patients at National Medical Center. The company has already conducted Phase 2 and 3 trials in coronavirus patients with mild symptoms. But the company concluded the interim Phase 2a study did not reach statistical significance.
[¨Ï Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Koreans spend record amount on alcohol, tobacco amid pandemic - Pulse by Maeil Business News Korea
- Korean shipyards to top global order book for third straight year in 2020 - Pulse by Maeil Business News Korea
- Hyundai, Kia target to sell about 7 million units in 2021, up 11.5% on year - Pulse by Maeil Business News Korea
- Kospi tests new highs as retailers drive bull run at the opening of the Year of Cow - Pulse by Maeil Business News Korea
- Daewoo E&C wins $2.67 port facilities deal in Iraq - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- AI·바이오·로봇…곳곳에 ‘교수님의 힘’
- 하이브 “法 판단 존중…민희진 해임건 찬성 의결권 행사 않을 것”(전문)[공식입장] - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이